My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 293

    1.
    2.

    Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.

    Walsh F, Carnegy F, Willcock J, Amyes S.

    J Antimicrob Chemother. 2004 May;53(5):793-6. Epub 2004 Mar 31.PMID: 15056640 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Discrepancy between antibiotics administered in acute exacerbations of chronic bronchitis and susceptibility of isolated pathogens in respiratory samples: multicentre study in the primary care setting.

    Querol-Ribelles JM, Molina J, Naberan K, Esteban E, Herreras A, Garcia-de-Lomas J.

    Int J Antimicrob Agents. 2006 Nov;28(5):472-6.PMID: 17046209 [PubMed - indexed for MEDLINE]Related articles

    4.

    Comparative activity of telithromycin against typical community-acquired respiratory pathogens.

    Buxbaum A, Forsthuber S, Graninger W, Georgopoulos A.

    J Antimicrob Chemother. 2003 Sep;52(3):371-4. Epub 2003 Jul 29.PMID: 12888585 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Clinical and bacteriological efficacy of the ketolide telithromycin against isolates of key respiratory pathogens: a pooled analysis of phase III studies.

    Low DE, Brown S, Felmingham D.

    Clin Microbiol Infect. 2004 Jan;10(1):27-36.PMID: 14706083 [PubMed - indexed for MEDLINE]Related articles

    8.

    Bacteriological efficacy of 5-day therapy with telithromycin in acute maxillary sinusitis.

    Buchanan P, Roos K, Tellier G, Rangaraju M, Leroy B.

    Int J Antimicrob Agents. 2005 Mar;25(3):237-46.PMID: 15737519 [PubMed - indexed for MEDLINE]Related articles

    9.

    Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000).

    Mendes C, Marin ME, Quiñones F, Sifuentes-Osornio J, Siller CC, Castanheira M, Zoccoli CM, López H, Súcari A, Rossi F, Angulo GB, Segura AJ, Starling C, Mimica I, Felmingham D.

    Braz J Infect Dis. 2003 Feb;7(1):44-61.PMID: 12807691 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Telithromycin: the first ketolide antimicrobial.

    Nguyen M, Chung EP.

    Clin Ther. 2005 Aug;27(8):1144-63. Review.PMID: 16199242 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of telithromycin and azithromycin on nasopharyngeal bacterial flora in patients with acute maxillary sinusitis.

    Brook I, Hausfeld JN.

    Arch Otolaryngol Head Neck Surg. 2006 Apr;132(4):442-5.PMID: 16618915 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Telithromycin: a ketolide antibiotic for treatment of respiratory tract infections.

    Lonks JR, Goldmann DA.

    Clin Infect Dis. 2005 Jun 1;40(11):1657-64. Epub 2005 Apr 22. Review.PMID: 15889365 [PubMed - indexed for MEDLINE]Related articles

    14.

    Activity of telithromycin and comparators against bacterial pathogens isolated from 1,336 patients with clinically diagnosed acute sinusitis.

    Dohar J, Cantón R, Cohen R, Farrell DJ, Felmingham D.

    Ann Clin Microbiol Antimicrob. 2004 Aug 2;3:15.PMID: 15287988 [PubMed]Related articlesFree article

    15.

    Comparative in-vitro activity of levofloxacin against isolates of bacteria from adult patients with community-acquired lower respiratory tract infections.

    Casellas JM, Gilardoni M, Tome G, Goldberg M, Ivanovic S, Orduna M, Dolmann A, Ascoli M, Ariza H, Montero JM.

    J Antimicrob Chemother. 1999 Jun;43 Suppl C:37-42.PMID: 10404336 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    In vitro activity of telithromycin against respiratory tract pathogens in comparison with other antimicrobial agents.

    Ling TK, Lee CC.

    Chemotherapy. 2005 Jul;51(4):182-5. Epub 2005 Jun 23.PMID: 15980628 [PubMed - indexed for MEDLINE]Related articles

    17.

    Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).

    Jacobs E, Dalhoff A, Korfmann G.

    Int J Antimicrob Agents. 2009 Jan;33(1):52-7. Epub 2008 Oct 1.PMID: 18835763 [PubMed - indexed for MEDLINE]Related articles

    19.

    Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the Ketolide Telithromycin: results from the PROTEKT surveillance study (1999-2000).

    Reinert RR, Rodloff AC, Halle E, Baer W, Beyreiss B, Seifert H, Wichelhaus TA, Maass M, Mehl M.

    Chemotherapy. 2004 Jun;50(3):143-51.PMID: 15272227 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)]

    Goto H, Takeda H, Kawai S, Watanabe S, Okazaki M, Shimada K, Nakano K, Yokouchi H, Mori T, Igari J, Oguri T, Yamamoto M, Kudo K, Kobayashi N, Tanaka T, Yoshimura K, Kawabata M, Nakamori Y, Sumitomo M, Inoue H, Nakadate T, Suwabe A, Ashino Y, Aoki N, Honma Y, Suzuki Y, Karasawa Y, Oka M, Kobashi Y, Kohno S, Hirakata Y, Kondou A, Matsuda J, Nakano M, Oikawa S.

    Jpn J Antibiot. 2008 Aug;61(4):209-40. Japanese. PMID: 19024644 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk